- Immunome (NASDAQ:IMNM) announced its plans to commence an underwritten public offering to issue and sell $125m of shares of its common stock.
- All the shares are being offered by Immunome.
- Immunome expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering.
- IMNM shares down 3.7% post-market on Wednesday.
- Source: Press release
